2026 NPPES data Foot Surgery Podiatrist NPI 1790871804 MD
Verify on CMS →

MARK ROSE, MD

Foot Surgery Podiatrist in NATICK, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
58
Medicare Part D claims · 32 beneficiaries · Foot Surgery Podiatrist avg: 342

What the federal data shows

MARK ROSE, MD filed 58 Medicare Part D claims in 2023 as a Foot Surgery Podiatrist in NATICK, Massachusetts.

58
Part D claims, 2023

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK ROSE, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

58 0th percentile higher than 0% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MARK ROSE, MD?

Quality data not reported

NPI registry status

Active

Issued 10/05/2006

NPI 1790871804

Primary specialty

Foot Surgery Podiatrist

Niche

1,519 US NPIs in this specialty

Medicare Part D claims

58 83% vs specialty avg

2023 prescription claims

Specialty avg: 342

Specialty distribution in Massachusetts

How Foot Surgery Podiatrist compares to other specialties among Massachusetts providers

Massachusetts providers

Foot Surgery Podiatrist share within Massachusetts

1. Foot Surgery Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Foot Surgery Podiatrist share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Foot Surgery Podiatrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Foot Surgery Podiatrist ABMS/AOA estimate

Est. board-certified rate (Foot Surgery Podiatrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Foot Surgery Podiatrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK ROSE, MD appears in the CMS NPPES registry as a Foot Surgery Podiatrist provider holding MD credentials at 67 UNION ST, NATICK, MA, 01760, with a listed phone of (508) 653-7311. NPI 1790871804 was issued on 10/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ROSE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 58 prescription claims written by this provider, covering 32 Medicare beneficiaries and totaling roughly $700 in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Foot Surgery Podiatrist is a narrow specialty nationwide, with 1,519 enrolled providers across 53 states and an average of 342 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

67 UNION ST
NATICK, MA 01760

Provider Details

NPI 1790871804
Specialty Foot Surgery Podiatrist
Credentials MD
Gender Male
NPI Issued 10/05/2006

Hospital and facility affiliations

Facilities where MARK ROSE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ORTHOPEDICS NEW ENGLAND INC
NATICK, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MARK ROSE, MD. To verify MARK ROSE, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

58
Total Claims
$700
Total Drug Cost
32
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
66
Total Day Supply
1,251
Brand Drug Cost
$0
Generic Drug Cost
$700

Patient Demographics

Average Patient Age
67.8 years
Avg HCC Risk Score
0.94

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Gabapentin
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Foot Surgery Podiatrist Overview

How MARK ROSE, MD fits within the Foot Surgery Podiatrist landscape nationally.

1,519
Foot Surgery Podiatrist Providers in US
53
States with Foot Surgery Podiatrist
342
Avg Claims per Provider

MARK ROSE, MD's 58 claims are below the specialty average of 342.

Nearby Foot Surgery Podiatrist Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as ROSE.

Compare Foot Surgery Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK ROSE, MD's specialty?
MARK ROSE, MD specializes in Foot Surgery Podiatrist and practices in NATICK, Massachusetts. Credentials: MD.
How much does MARK ROSE, MD prescribe under Medicare Part D?
In 2023, MARK ROSE, MD wrote 58 Medicare Part D claims totaling $700 in drug costs for 32 beneficiaries.
Where is MARK ROSE, MD located?
MARK ROSE, MD is located at 67 UNION ST, NATICK, MA, 01760. Phone: (508) 653-7311.
What is MARK ROSE, MD's NPI number?
MARK ROSE, MD's National Provider Identifier (NPI) is 1790871804, issued on 10/05/2006.
How many Foot Surgery Podiatrist providers are there in the US?
There are 1,519 Foot Surgery Podiatrist providers across 53 states in the US. The average Foot Surgery Podiatrist provider writes 342 Medicare Part D claims per year.
What drugs does MARK ROSE, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK ROSE, MD's most frequently prescribed drugs include Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK ROSE, MD accept Medicare?
MARK ROSE, MD appears in CMS Medicare data with 58 Part D claims and 32 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK ROSE, MD's credentials?
MARK ROSE, MD's NPI is 1790871804 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology